Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group37

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group19

Views

Views
November 20243
December 20241
January 20252
February 20255
March 20255
April 20253
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Singapore5
Germany3
Spain1
 

Top cities views

Views
Frankfurt am Main2
Council Bluffs1
Nuremberg1